Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 1;123(19):3744-3753.
doi: 10.1002/cncr.30809. Epub 2017 Jun 16.

Primary care visit use after positive fecal immunochemical test for colorectal cancer screening

Affiliations

Primary care visit use after positive fecal immunochemical test for colorectal cancer screening

Grace Clarke Hillyer et al. Cancer. .

Abstract

Background: For some patients, positive cancer screening test results can be a stressful experience that can affect future screening compliance and increase the use of health care services unrelated to medically indicated follow-up.

Methods: Among 483,216 individuals aged 50 to 75 years who completed a fecal immunochemical test to screen for colorectal cancer at a large integrated health care setting between 2007 and 2011, the authors evaluated whether a positive test was associated with a net change in outpatient primary care visit use within the year after screening. Multivariable regression models were used to evaluate the relationship between test result group and net changes in primary care visits after fecal immunochemical testing.

Results: In the year after the fecal immunochemical test, use increased by 0.60 clinic visits for patients with true-positive results. The absolute change in visits was largest (3.00) among individuals with positive test results who were diagnosed with colorectal cancer, but significant small increases also were found for patients treated with polypectomy and who had no neoplasia (0.36) and those with a normal examination and no polypectomy performed (0.17). Groups of patients who demonstrated an increase in net visit use compared with the true-negative group included patients with true-positive results (odds ratio [OR], 1.60; 95% confidence interval [95% CI], 1.54-1.66), and positive groups with a colorectal cancer diagnosis (OR, 7.19; 95% CI, 6.12-8.44), polypectomy/no neoplasia (OR, 1.37; 95% CI, 1.27-1.48), and normal examination/no polypectomy (OR, 1.24; 95% CI, 1.18-1.30).

Conclusions: Given the large size of outreach programs, these small changes can cumulatively generate thousands of excess visits and have a substantial impact on total health care use. Therefore, these changes should be included in colorectal cancer screening cost models and their causes investigated further. Cancer 2017;123:3744-3753. © 2017 American Cancer Society.

Keywords: colorectal cancer; delivery of health care; early detection of cancer; primary health care.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have no conflicts to disclose.

Figures

Figure 1A–D
Figure 1A–D
Unadjusted change in cumulative monthly healthcare utilization within FIT screening result groups comparing the 12 month period prior to FIT to the 12 month period after Kaiser Permanente Northern California between 2007 and 2011.
Figure 2A–E
Figure 2A–E
Unadjusted change in cumulative monthly healthcare utilization within FIT-positive screening result subgroups comparing the 12 month period prior to FIT to the 12 month period after Kaiser Permanente Northern California between 2007 and 2011.

Similar articles

References

    1. Luo Z, Bradley CJ, Dahman BA, Gardiner JC. Colon cancer treatment costs for Medicare and dually eligible beneficiaries. Health Care Financ Rev. 2010;31(1):35–50. - PMC - PubMed
    1. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58(3):130–160. - PubMed
    1. United States Preventive Services Task Force. AHRQ Publication 08-05124-EF-3. Rockville, MD: Agency for Healthcare Research and Quality; 2008. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement.
    1. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected] Am J Gastroenterol. 2009;104(3):739–750. - PubMed
    1. Klabunde CN, Joseph DA, King JB, White A, Plescia M. Colorectal Cancer Screening Test Use - United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(Early Release):1–8. - PubMed